Ramsay Health Care Ltd (ASX: RHC) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Ramsay Health Care Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $8.70 billion
P/E Ratio 36.07
Dividend Yield 1.92%
Shares Outstanding 230.25 million
Earnings per share 1.152
Dividend per share 0.80
Year To Date Return -23.89%
Earnings Yield 2.77%
Franking 100%
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Ramsay Health Care Ltd (ASX: RHC)
    Latest News

    A woman looks excited as she holds Australian dollars in the air.
    Dividend Investing

    ASX shares are paying out $19 billion in dividends this week. Are you getting a piece?

    There are dozens of shares that will pay dividends this week. Are yours on the list?

    Read more »

    A boy stands in front of two similar but slightly different doors, scratching his head as to which one to choose.
    Share Fallers

    These ASX 200 shares just plunged. Which one's the bargain?

    Both these popular stocks have fallen significantly over the last month. Which one's the best buy-the-dip investment?

    Read more »

    A woman crosses her hands in front of her body in a defensive stance indicating a trading halt.
    Broker Notes

    3 'defensive growth' ASX shares perfect for the current climate: expert

    Defence doesn't mean you sacrifice growth. Here's a trio of stocks that will let you have your cake and eat…

    Read more »

    a small child in a judo outfit with a green belt strikes a martial arts pose with his hand thrust forward and a cute smile on his face.
    Defensive Shares

    Where I would go hunting for defensive ASX 200 shares with upside

    Defensive shares can help protect your portfolio, but here's what to look out for.

    Read more »

    Five people are leaping in the shallows of the beach water as sunset shines gold on them.
    Dividend Investing

    5 high-profile ASX 200 shares that will trade ex-dividend on Monday

    You'd better be quick if you want the latest dividends from these shares...

    Read more »

    A black cat waiting to pounce on a mouse.
    Investing Strategies

    6 ASX shares to pounce on from a boom reporting season: Morgans

    Analyst picks half-a-dozen best stocks to buy right now on the back of their recent results.

    Read more »

    Green dollar sign rocket on the back of a man.
    Dividend Investing

    Passive income watch: 4 ASX 200 shares that announced boosted dividends this week

    Shareholders are getting a pay rise from these income shares in 2023.

    Read more »

    a doctor in white coat and stethoscope stands in front of a building holding an electronic device in his hands.
    Earnings Results

    Ramsay share price jumps on 22% profit boost 

    Its earnings more than doubled last quarter as COVID impacts abated.

    Read more »

    A man sitting at his dining table looks at his laptop and ponders the CSL balance sheet and the value of CSL shares today
    Mergers & Acquisitions

    6 asset-rich ASX 200 shares to buy for their takeover potential: expert

    These half-dozen stocks have just the attributes that would have private equity licking their lips.

    Read more »

    A woman sits at her computer with her hand to her mouth and a contemplative smile on her face as she reads about the performance of Allkem shares on her computer
    Growth Shares

    3 excellent ASX 200 shares to buy and hold for a decade: analysts

    These ASX 200 shares could be worth holding onto for the long term...

    Read more »

    A doctor in a white coat sits at her computer with finger on mouth thinking about something in her office with medical equipment in the background.
    Healthcare Shares

    Why did ASX 300 healthcare stock Polynovo tumble 12% today?

    Polynovo had a shocker on Wednesday. Let's look at why...

    Read more »

    couple having a happy discussion with a banker
    Investing Strategies

    Avoid my biggest mistake in investing: fund manager

    Ask A Fund Manager: Schroders' Ray David also picks the stock he would happily hold onto for the next four…

    Read more »

    Frequently Asked Questions

    Yes, Ramsay Health Care has historically paid two fully franked dividends a year.

    Ramsay Health Care generally pays its shareholder dividends in March and September. 

    Ramsay Health Care Ltd listed on the ASX on 24 September 1997.

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    04 Sep 2024 $0.4000 100.00% Final 26 Sep 2024
    11 Mar 2024 $0.4000 100.00% Interim 05 Apr 2024
    06 Sep 2023 $0.2500 100.00% Final 29 Sep 2023
    06 Mar 2023 $0.5000 100.00% Interim 30 Mar 2023
    05 Sep 2022 $0.4850 100.00% Final 29 Sep 2022
    07 Mar 2022 $0.4850 100.00% Interim 31 Mar 2022
    06 Sep 2021 $1.0300 100.00% Final 30 Sep 2021
    08 Mar 2021 $0.4850 100.00% Interim 31 Mar 2021
    05 Mar 2020 $0.6250 100.00% Interim 27 Mar 2020
    05 Sep 2019 $0.9150 100.00% Final 30 Sep 2019
    06 Mar 2019 $0.6000 100.00% Interim 29 Mar 2019
    05 Sep 2018 $0.8650 100.00% Final 28 Sep 2018
    06 Mar 2018 $0.5750 100.00% Interim 29 Mar 2018
    05 Sep 2017 $0.0000 100.00% Final 28 Sep 2017
    07 Mar 2017 $0.5300 100.00% Interim 29 Mar 2017
    06 Sep 2016 $0.7200 100.00% Final 29 Sep 2016
    08 Mar 2016 $0.4700 100.00% Interim 30 Mar 2016
    08 Sep 2014 $0.5100 100.00% Final 24 Sep 2014
    04 Mar 2014 $0.3400 100.00% Interim 26 Mar 2014
    03 Sep 2013 $0.4150 100.00% Final 25 Sep 2013
    04 Mar 2013 $0.2900 100.00% Interim 27 Mar 2013
    05 Mar 2012 $0.2550 100.00% Interim 28 Mar 2012
    02 Sep 2011 $0.2950 100.00% Final 26 Sep 2011
    08 Mar 2011 $0.2250 100.00% Interim 28 Mar 2011
    31 Aug 2010 $0.2500 100.00% Final 27 Sep 2010
    16 Mar 2010 $0.1850 100.00% Interim 09 Apr 2010
    21 Sep 2009 $0.2150 100.00% Final 09 Oct 2009
    20 Mar 2009 $0.1650 100.00% Interim 08 Apr 2009
    25 Sep 2008 $0.1750 100.00% Final 15 Oct 2008
    26 Sep 2007 $0.1600 100.00% Final 12 Oct 2007
    27 Mar 2006 $0.1050 100.00% Interim 12 Apr 2006
    26 Sep 2005 $0.1150 100.00% Final 14 Oct 2005
    16 Apr 2004 $0.0750 100.00% Interim 30 Apr 2004

    RHC ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Ramsay Health Care Ltd

    Ramsay Health Care Ltd (ASX: RHC) is one of the largest private healthcare providers in the world, with around 500 facilities across 11 countries. Its operations cover Australia, Europe, the UK, and Asia. 

    As well as private hospitals, Ramsay operates day surgeries, primary care clinics, diagnostic and imaging centres, mental health facilities, pharmacies, and an expanding range of in-home and community care services.

    It is the largest private hospital group in Australia, France, and the Scandanavian countries. Its 52.5%-owned subsidiary Ramsay Sante oversees its European operations. Its UK business includes mental health facilities and a range of clinical specialties.

    The vast majority of the company's revenue is generated from its Australian and European operations.

    RHC Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    13 Nov 2024 $37.63 $-0.79 -2.06% 420,038 $38.02 $38.15 $37.63
    12 Nov 2024 $38.42 $-0.01 -0.03% 804,657 $38.47 $38.60 $38.06
    11 Nov 2024 $38.43 $-0.29 -0.75% 374,196 $38.62 $38.95 $38.38
    08 Nov 2024 $38.72 $0.32 0.83% 687,770 $38.49 $39.11 $38.20
    07 Nov 2024 $38.40 $0.12 0.31% 536,061 $38.37 $38.65 $37.97
    06 Nov 2024 $38.28 $-0.99 -2.52% 430,418 $39.68 $39.81 $38.17
    05 Nov 2024 $39.27 $-0.22 -0.56% 269,255 $39.28 $39.56 $39.10
    04 Nov 2024 $39.49 $0.21 0.53% 359,173 $39.51 $39.91 $39.26
    01 Nov 2024 $39.28 $-0.89 -2.22% 501,469 $40.05 $40.18 $39.28
    31 Oct 2024 $40.17 $-0.61 -1.50% 557,197 $40.69 $40.76 $40.11
    30 Oct 2024 $40.78 $-0.28 -0.68% 298,313 $41.00 $41.25 $40.68
    29 Oct 2024 $41.06 $-0.43 -1.04% 384,205 $41.53 $41.88 $41.06
    28 Oct 2024 $41.49 $-0.21 -0.50% 209,366 $41.70 $41.85 $41.28
    25 Oct 2024 $41.70 $-0.07 -0.17% 303,824 $41.77 $41.99 $41.43
    24 Oct 2024 $41.77 $-0.04 -0.10% 440,516 $41.63 $42.43 $41.61
    23 Oct 2024 $41.81 $0.13 0.31% 291,738 $41.70 $42.08 $41.45
    22 Oct 2024 $41.68 $-0.72 -1.70% 501,757 $42.10 $42.24 $41.67
    21 Oct 2024 $42.40 $0.04 0.09% 588,447 $42.39 $42.73 $42.25
    18 Oct 2024 $42.36 $-0.42 -0.98% 689,092 $42.77 $42.90 $42.36
    17 Oct 2024 $42.78 $0.20 0.47% 735,317 $43.10 $43.30 $42.70
    16 Oct 2024 $42.58 $-0.76 -1.75% 816,291 $42.93 $43.05 $42.51
    15 Oct 2024 $43.34 $0.67 1.57% 530,494 $42.73 $43.47 $42.73

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    05 Sep 2024 David Thodey Buy 2,475 $100,485
    On-market trade.
    04 Sep 2024 Helen Kurincic Buy 2,000 $81,159
    On-market trade.
    04 Sep 2024 Karen Penrose Buy 1,225 $49,884
    On-market trade.
    28 Aug 2024 Craig McNally Expiry 57,690 $2,532,014
    As advised by the company. Lapsed, 114,439 Rights
    22 Dec 2023 Claudia Dyckerhoff Buy 2,500 $128,275
    On-market trade.
    15 Dec 2023 Craig McNally Issued 64,625 $3,261,623
    Issue of securities. 172,129 Performance Rights
    20 Nov 2023 Karen Penrose Buy 195 $9,935
    On-market trade.
    16 Nov 2023 David Thodey Buy 4,000 $210,509
    On-market trade.
    15 Nov 2023 Karen Penrose Buy 665 $34,972
    On-market trade.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr David Ingle Thodey Non-Executive DirectorNon-Executive Chairman Nov 2017
    Mr Thodey is a business leader focused on innovation, technology, digital transformation, and corporate governance, with more than 40 years of experience. In addition to being Chair of Ramsay, Mr Thodey is currently Chair of Xero Limited (a global cloud-based accounting solution for small and medium businesses). He is also Chancellor the University of Sydney, and co-Chair of the Great Barrier Reef Foundation.
    Ms Catriona Alison Deans Non-Executive Director Nov 2018
    Ms Deans has 25 years of experience building technology-enabled businesses involved in media, ecommerce, financial services, and health, and across leadership roles as an executive, a director and in venture capital. Ms Deans is also Chair of Cochlear Limited and a Non-Executive Director of Calix Limited, Fitness Passport and Deputy Pty Ltd. She is also a Venture Partner of Main Sequence Ventures.
    Mr Michael Stanley Siddle Non-Executive Director May 1975
    Mr Siddle has experience in the management of private hospitals and has been integrally involved in Ramsay Health Care's expansion through developments, mergers, and acquisitions.
    Mr Craig Ralph McNally Chief Executive OfficerManaging Director Jul 2017
    Mr McNally has worked across operational, strategic, and financial roles. For the past two decades, Mr McNally has been responsible for the development and implementation of its growth strategy including brownfield expansions, international market assessments, mergers and acquisitions and new business strategies. He has been at the forefront of all the acquisitions and deals.
    Ms Helen Kurincic Non-Executive Director Mar 2024
    Ms Kurincic brings operational, executive, and board-level experience in a range of Australian based healthcare organisations. In addition to serving on the Ramsay Board, Ms Kurincic is currently Chair of McMillan Shakespeare and a director of Carlton Football Club. Ms Kurincic's previous health sector roles include Non-Executive Director of private health insurer HBF Health, Estia Health, Integral Diagnostics (Chair), Sirtex Medical, Domain Principal Group, public hospital service provider Melbourne Health, Orygen Youth Mental Health Research Centre and DCA Group.
    Ms Karen Lee Collett Penrose Non-Executive Director Mar 2020
    Ms Penrose has had an executive career in leadership and CFO roles, mainly in financial services. She is familiar in financial management, customer outcomes and operating in a rapidly changing regulatory environment which stems from 20 years in banking with Commonwealth Bank and HSBC and eight years as a listed-company CFO. She is also a member of the Risk Management Committee.
    Mr Steven Andrew Sargent Non-Executive Director Nov 2021
    Mr Sargent is Chair of the Risk Management Committee. His executive career included 22 years at General Electric, where he gained multi-industry, international experience leading businesses in industries including healthcare, energy and financial services across the USA, Europe and Asia Pacific. Mr Sargent is currently a Non-Executive Director of Origin Energy Limited and Chair of infection prevention company Nanosonics Limited.
    Ms Claudia Ricarda Rita Sussmuth Dyckerhoff Non-Executive Director Oct 2018
    Ms Dyckerhoff bringing expertise in market growth strategies, business development and operational performance improvement in hospitals. Dr Sussmuth Dyckerhoff has global experience in hospitals and health care across Europe, Asia, and the USA. She joined McKinsey and Company in Switzerland in 1995 and transferred to the USA focusing on supporting health care companies, including pharmaceutical/medical device companies, payor, provider and health systems in Europe and the USA. In 2006, Dr Sussmuth Dyckerhoff transferred to China, was elected Senior Partner in 2010 and supported health care companies as well as governments across Asia. She is also a member of the Risk Management Committee.
    Mr James Malcolm McMurdo Non-Executive Director Sep 2019
    Mr McMurdo has more than 30 years of finance and banking experience. He has a background in corporate advisory spanning across mergers and acquisitions, strategic advisory and financing with experience across multiple industries including the healthcare sector. He has held senior operating management roles and worked extensively in both the Asia Pacific and European regions. Mr McMurdo is one of the Founding Partners of Privatus Capital Partners, an advisory and merchant banking business. Prior to establishing Privatus, he held senior management roles at Deutsche Bank and was based in Hong Kong. In the time he was at Deutsche Bank, Mr McMurdo was Global Co-Head of Corporate Finance, Head of Corporate and Investment Bank for Asia Pacific and CEO for Australia and New Zealand.
    Ms Henrietta Rowe Company SecretaryGroup General Counsel Jun 2019
    -
    Henrietta Rowe Company SecretaryGroup General Counsel
    -
    Martyn Roberts Group Chief Financial Officer
    -
    Collen Harris Group Chief People Officer
    -
    Andrew Wearne Group Chief Risk Officer
    -
    Rachna Gandhi Group Chief Transformational and Digital Officer
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    HSBC Custody Nominees (Australia) Limited 51,231,592 22.30%
    J P Morgan Nominees Australia Pty Limited 34,633,790 15.07%
    Netwealth Investments Limited <Wrap Services A/C> 23,452,113 10.21%
    Paul Ramsay Holdings Pty Limited 19,495,410 8.48%
    Citicorp Nominees Pty Limited 19,340,054 8.42%
    National Nominees Limited 4,675,258 2.04%
    Woolwich Investments Pty Ltd <The Siddle Family Trust> 2,750,000 1.20%
    BNP Paribas Noms Pty Ltd 2,655,835 1.16%
    Washington H Soul Pattinson And Company Limited 2,320,085 1.01%
    BNP Paribas Nominees Pty Ltd <Hub24 Custodial Serv Ltd> 2,098,434 0.91%
    Argo Investments Limited 2,033,197 0.89%
    BNP Paribas Nominees Pty Ltd <Agency Lending Collateral > 1,663,500 0.72%
    Warbont Nominees Pty Ltd <Unpaid Entrepot A/C> 1,645,543 0.72%
    Custodial Services Limited <Beneficiaries Holding A/C> 1,632,137 0.71%
    HSBC Custody Nominees (Australia) Limited <Nt Comnwlth Super Corp A/C> 1,327,444 0.58%
    BNP Paribas Nominees Pty Ltd <Agency Lending A/C> 1,017,896 0.44%
    HSBC Custody Nominees (Australia) Limited Gsi Eda 1,000,138 0.43%
    Australian Foundation Investment Company Limited 1,000,000 0.43%
    UBS Nominees Pty Ltd 897,160 0.39%
    Certane Ct Pty Ltd <Ramsay Unallocated Ac> 778,088 0.34%

    Profile

    since

    Note